Clinical Trials Logo

Clinical Trial Summary

In this study; Changes in appetite, hormones and growth of ventricular septal defect patients treated with non-surgical method were evaluated.


Clinical Trial Description

The study included 20 patients whose ventricular septal defect closed percutaneously and 26 children as control group. The symptoms, anthropometric measurements and laboratory tests of patient group were recorded at initial, 1st month and 6th months after closure. Anthropometric measurements; weight for age (WFA), height for age (HFA), body mass index (BMI) and their z scores, triceps skinfold thickness (TSF) and mid-upper arm circumference (MUAC) were recorded on admission. Patients with weight for height z score less than -2 were defined as malnutrition. Questions about the symptoms like appetite, weight gain, frequency of illness, rate of breathing, fatigue were asked to all parents at initial. These questionnaires15 and visual analogue scale (for appetite) were repeated at 1st and 6th month visits. During the initial evaluation, approximately 6 ml of venous blood samples were taken between 9:00-10:00 am after an average of 10 hours fasting. On the same day, IGFBP-3, Ghrelin and leptin,fasting blood glucose, insulin, IGF-1, IGFBP-3, aspartate aminotransferase (AST) and alanine aminotransferase (ALT), total protein, and albumin were measured. Anthropometric measurements and laboratory tests were repeated at 1st and 6th month visits. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05200910
Study type Observational
Source Kayseri City Hospital
Contact
Status Completed
Phase
Start date July 16, 2018
Completion date January 1, 2020

See also
  Status Clinical Trial Phase
Completed NCT03684161 - Cardiopulmonary Function in Adults Born With a Ventricular Septal Defect
Completed NCT01120964 - Intravenous L-Citrulline to Treat Children Undergoing Heart Bypass Surgery : Revised Protocol Phase 1/Phase 2
Completed NCT02914652 - The Cardiopulmonary Effect of Inhaled Beta-2-agonists on Adult Patients Born With Ventricular Septum Defects. Phase 4
Recruiting NCT05939713 - Cera™ VSD Occluder Post Market Clinical Follow-up
Recruiting NCT05688670 - Regional Anesthesia Following Pediatric Cardiac Surgery Phase 4
Completed NCT02138435 - Longterm Outcome After Ventricular Septal Defect Closure N/A
Not yet recruiting NCT06298344 - The Role of Thiamine After Transcatheter Closure in Children With Left-to-Right Shunt Congenital Heart Disease Early Phase 1
Recruiting NCT05253209 - A Study Evaluating the Efficacy and Safety of IV L-Citrulline for the Prevention of Clinical Sequelae of Acute Lung Injury Induced by Cardiopulmonary Bypass in Pediatric Patients Undergoing Surgery for Congenital Heart Defects Phase 3
Completed NCT00556361 - Use of Ketamine Prior to Cardiopulmonary Bypass in Children Phase 2
Recruiting NCT03127748 - Cardiac Function After Transcatheter VSD Closure N/A
Enrolling by invitation NCT06214182 - Immune Heterogeneity Before and After Cardiopulmonary Bypass in Children
Active, not recruiting NCT04667455 - Improving Care for Children With Congenital Heart Disease. N/A
Active, not recruiting NCT04417712 - Lifetech MFO Post-Market Clinical Follow-Up Study
Completed NCT01313832 - The Effect of Remote Ischemic Preconditioning on the Ischemic Reperfusion Injury in Infants With Ventricular Septal Defect and Pulmonary Hypertension N/A
Active, not recruiting NCT04017975 - Optical Tissue Identification for Myocardial Architecture Phase 2
Completed NCT01915277 - A Phase I Study of Dexmedetomidine Bolus and Infusion in Corrective Infant Cardiac Surgery: Safety and Pharmacokinetics Phase 1
Recruiting NCT03941691 - A Trial to Evaluate the Safety and Efficacy of a Fully Degradable Ventricular Septal Defect (VSD) Closure N/A
Completed NCT04859036 - The Effect of Transcatheter Ventricular Septal Defect Closure on Heart Rate Variability Parameters